Skip to main content

Table 3 Results of the Glasgow Benefit Inventory (GBI) and of the Specific Benefits from Tonsillectomy Inventory (SBTI)

From: Clinical significance and diagnostic usefulness of serologic markers for improvement of outcome of tonsillectomy in adults with chronic tonsillitis

Score Chronic tonsillitis Peritonsillar abscess p**
Mean SD* Mean SD*
GBI total score (T180) 24.2 20.9 7.8 15.5 0.013
GBI subscores (T180)
  General health 25.6 21.4 7.0 17.0 0.009
  Social support 6.7 20.5 2.1 5.7 0.965
  Physical functioning 45.2 42.2 16.7 32.2 0.013
SBTI (T-1)
  Total score -3.0 37.0 52.7 39.0 <0.0001
  Symptom score -0.8 32.7 47.0 44.7 <0.0001
  Resources -5.3 46.7 68.3 37.4 <0.0001
SBTI (T180)
  Total score 68.8 41.3 67.9 34.3 0.571
  Symptom score 66.7 40.8 62.2 33.0 0.412
  Resources 72.5 43.7 76.2 39.1 0.891
  Benefit 61.9 32.2 40.6 31.5 0.059
SBTI (ΔT***)
  Total score 74.12 68.77 22.44 57.47 0.030
  Symptom score 67.50 63.63 20.24 58.90 0.049
  Resources 81.58 76.95 23.08 59.14 0.024
Absolute number of patients with changes of SBTI score between T-1 and T180 (ΔT***) N****   N****   p**
  Total score 0.132
   Improved 15   7   
   Unchanged/deteriorated 4   6   
  Symptom score 0.150
   Improved 16   8   
   Unchanged/deteriorated 4   6   
  Resources 0.146
   Improved 16   8   
   Unchanged/deteriorated 3   5   
  1. *SD standard deviation; **p p value due to Mann–Whitney U test; significant p values (<0.05) in bold; ***the scores at T108 were subtracted from the values at T-1; ****the sample size N could be smaller than 24 as not all patients answered the SBTI T180 or answered all questions.